Identification of a biomarker to predict doxorubicin/cisplatin chemotherapy efficacy in osteosarcoma patients using primary, recurrent and metastatic specimens
CTSG and its associated NETs are potential biomarkers with which the efficacy of doxorubicin/cisplatin chemotherapy could be predicted in OS patients.
Authors
- Fuqin Zhang (ORCID: https://orcid.org/0000-0002-9909-0135)
- Qiao Liu (ORCID: https://orcid.org/0000-0001-8739-6236)
- Qiong Ma
- Xiaoyu Zhang (ORCID: https://orcid.org/0009-0004-1595-690X)
- Wei Zhang (ORCID: https://orcid.org/0009-0003-8120-942X)
- Yonghong Wu (ORCID: https://orcid.org/0009-0005-8032-9985)
- Fu Jin (ORCID: https://orcid.org/0000-0002-8883-9411)
- Li Gong
- Yanhua Wen (ORCID: https://orcid.org/0009-0002-6867-4602)
- Jin Sun
Institutions
- Tang Du Hospital (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1016/j.tranon.2024.102098
- Citations
- 2
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Shaanxi Provincial Science and Technology Department